 CAMBRIDGE, Mass., Jan. 24, 2023 GLOBE NEWSWIRE Synlogic, Inc. Nasdaq: SYBX, the leading company advancing therapeutics based on synthetic biology, today announced it will participate in the following upcoming investor and industry conferences: BIO CEO Investor Conference: Molly Harper, Chief Business Officer, and Michael Jensen, Chief Financial Officer, will participate in-person and virtually at ... The post Synlogic Announces Participation in Upcoming Investor and Industry Conferences... 